---
figid: PMC6938984__gr1
figlink: /pmc/articles/PMC6938984/figure/fig1/
number: F1
caption: Biased Agonism in FPR Signaling During Post–Myocardial Infarction(A) Different
  formyl peptide receptor (FPR) ligands can activate the same FPR for a diverse array
  of possible outcomes depending on the ligand itself. FPR agonist 1 activates a subset
  of signal transduction pathways for outcome 1 while not activating or suppressing
  the other outcomes, whereas FPR agonist 2 activates only the pathway leading to
  outcome 4, which highlight multiple possible combinations. (B) Schematic representation
  of potential mechanisms behind the observation of increased CD206+/arginase-1 (Arg-1)+
  macrophages in the heart following treatment with FPR agonists. One scenario is
  that upon engagement with FPR agonists, monocytes are prespecified to a proreparative
  fate from the systemic effects of the FPR agonist. Thus, after entering the tissue,
  irrespective of the cardiac microenvironment, the monocytes differentiate into CD206+/Arg-1+
  macrophages. Another possibility is that monocytes in circulation, despite engagement
  with FPR agonists at this stage, are conditioned by the tissue microenvironment,
  and not FPR stimulation, to adopt a CD206+/Arg-1+ fate within the heart (Created
  with BioRender).
pmcid: PMC6938984
papertitle: Therapeutic Treatment Approaches Post–Myocardial Infarction.
reftext: Rysa Zaman, et al. JACC Basic Transl Sci. 2019 Dec;4(8):921-923.
pmc_ranked_result_index: '155624'
pathway_score: 0.7355656
filename: gr1.jpg
figtitle: Biased Agonism in FPR Signaling During Post–Myocardial Infarction(A) Different
  formyl peptide receptor (FPR) ligands can activate the same FPR for a diverse array
  of possible outcomes depending on the ligand itself
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6938984__gr1.html
  '@type': Dataset
  description: Biased Agonism in FPR Signaling During Post–Myocardial Infarction(A)
    Different formyl peptide receptor (FPR) ligands can activate the same FPR for
    a diverse array of possible outcomes depending on the ligand itself. FPR agonist
    1 activates a subset of signal transduction pathways for outcome 1 while not activating
    or suppressing the other outcomes, whereas FPR agonist 2 activates only the pathway
    leading to outcome 4, which highlight multiple possible combinations. (B) Schematic
    representation of potential mechanisms behind the observation of increased CD206+/arginase-1
    (Arg-1)+ macrophages in the heart following treatment with FPR agonists. One scenario
    is that upon engagement with FPR agonists, monocytes are prespecified to a proreparative
    fate from the systemic effects of the FPR agonist. Thus, after entering the tissue,
    irrespective of the cardiac microenvironment, the monocytes differentiate into
    CD206+/Arg-1+ macrophages. Another possibility is that monocytes in circulation,
    despite engagement with FPR agonists at this stage, are conditioned by the tissue
    microenvironment, and not FPR stimulation, to adopt a CD206+/Arg-1+ fate within
    the heart (Created with BioRender).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FPR1
  - Arg
genes:
- word: FPR
  symbol: FPR
  source: hgnc_alias_symbol
  hgnc_symbol: FPR1
  entrez: '2357'
- word: FPR
  symbol: FPR
  source: hgnc_alias_symbol
  hgnc_symbol: FPR1
  entrez: '2357'
- word: FPR
  symbol: FPR
  source: hgnc_alias_symbol
  hgnc_symbol: FPR1
  entrez: '2357'
chemicals:
- word: Arg
  source: MESH
  identifier: C076685
diseases: []
figid_alias: PMC6938984__F1
redirect_from: /figures/PMC6938984__F1
figtype: Figure
---
